Clinical Trials in Arizona

Showing 4621-4640 of 16,770 trials

Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring

NCT04906369

This study evaluates if blood tests can detect changes in disease status during treatment for stage IV breast cancer. Information from this study may help researchers learn more about metastatic breast cancer and how to optimize treatment.

Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8

Mayo Clinic150 participantsStarted Nov 2020

Scottsdale, Arizona, United States

COMPLETEDPhase 131 miles

A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

NCT05075564

The purpose of this first-in-human, open-label, multicenter, non-randomized study is to investigate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary clinical activity of ES002023 in patients with advanced solid tumors that are relapsed or refractory to standard therapies.

Advanced Solid Tumor

Elpiscience Biopharma, Ltd.8 participantsStarted Dec 2021

Scottsdale, Arizona, United States • Fayetteville, Arkansas, United States • Los Angeles, California, United States +4 more locations

COMPLETEDNA31 miles

STEM-Parkinson's Disease

NCT04797611

This is a double-blinded, controlled, and randomized clinical trial (RCT) to establish the safety and efficacy of a non-invasive neuromodulation device for treating symptoms associated with Parkinson's disease.

Parkinson DiseaseParkinson's Disease and Parkinsonism

Scion NeuroStim188 participantsStarted May 2022

Scottsdale, Arizona, United States • Los Angeles, California, United States • Englewood, Colorado, United States +20 more locations

Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring

A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

STEM-Parkinson's Disease

Find Trials by Condition in Arizona

GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year

Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)

Pediatric ACL: Understanding Treatment Options

A Study of IMR-687 in Subjects With Sickle Cell Disease

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)

Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices

A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD

Tornier Shoulder Outcomes Study to Examine Safety and Functional Outcomes in Shoulder Arthroplasty and Fracture Patients

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Changing the Paradigm of In-Hospital Cardiopulmonary Resuscitation

Mohala Na Pua: Community-driven Drug Prevention